(Q33970462)

30 July 2017

1 reference

title

Molecular basis of the spectrum of skeletal complications of neoplasia (English)

1 reference

30 July 2017

Goltzman D

1

1 reference

30 July 2017

Karaplis AC

series ordinal

2

1 reference

30 July 2017

Kremer R

series ordinal

3

1 reference

30 July 2017

Rabbani SA

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

88

1 reference

30 July 2017

issue

12 Suppl

1 reference

30 July 2017

page(s)

2903-2908

1 reference

Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and nonhumoral groups.

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Purification of peptides with parathyroid hormone-like bioactivity from human and rat malignancies associated with hypercalcemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Parathyroid hormone-related protein purified from a human lung cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

An amino-terminal fragment of urokinase isolated from a prostate cancer cell line (PC-3) is mitogenic for osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Isolation and characterization of multiple isoforms of the rat urokinase receptor in osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Oncogenous osteomalacia. Review of the world literature of 42 cases and report of two new cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

X-linked hypophosphataemia: a homologous phenotype in humans and mice with unusual organ-specific gene dosage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Cloning of human PEX cDNA. Expression, subcellular localization, and endopeptidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

N-terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: identification of parathyroid hormone-like and parathyroid hormone-unlike domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Circulating concentrations of parathyroid hormone-like peptide in malignancy and in hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Effects of passive immunization against parathyroid hormone (PTH)-like peptide and PTH in hypercalcemic tumor-bearing rats and normocalcemic controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

Induction in human osteoblastic cells (SaOS2) of the early response genes fos, jun, and myc by the amino terminal fragment (ATF) of urokinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820000615%2988%3A12%2B%3C2903%3A%3AAID-CNCR4%3E3.0.CO%3B2-G

10.1002/1097-0142(20000615)88:12+<2903::AID-CNCR4>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference